Molecular Vision’s previous chairman, chris wright, will continue to serve on the board as a non-executive director.
The appointment serves to strengthen the board as the company prepares to commercialise its novel detection technology, focussing on low cost POC diagnostic tests in a minaturised, easy-to-use, disposable format.
Commenting on the appointment Ian Campbell, chief executive officer, Molecular Vision, said: “We are delighted to attract someone of Peter’s calibre. His extensive experience and expertise of the global diagnostics industry perfectly complement the range of skills offered by the existing members of the Board.”
Woodford commented: “I am excited by the clear potential of Molecular Vision’s technology platform, and look forward to working with the team as we move towards commercialisation.”